06-08_0300_Prompt05_RymanHealthcareLatest
2026-06-08_0300_Prompt05_RymanHealthcareLatest
Sector evidence
Sector body
June 2026
Next review not yet scheduled
New Zealand
Medium confidence
published
SNZ editorial review
Evidence boundary: This record summarises the cited source. It does not establish local availability, individual eligibility, or professional advice.
Short Answer
The FY26 Annual Report (year ended 31 March 2026) was published 5 June 2026.
Key Points
- •Operating revenue up 10% to $849M
- •Operating EBITDAF up 94% to $88M (nearly doubled)
- •First positive free cash flow in a decade: $188M
- •PBTF loss reduced from -$385M to -$73M
- •Gearing at sector-low 27.8% — balance sheet reset complete
- •Total ORA sales: 1,410 for FY26 (in line with 1,300–1,400 guidance)
Full Summary & Notes
The FY26 Annual Report (year ended 31 March 2026) was published 5 June 2026. The KB already holds: - '11_Market_and_Industry_Reports/2026 - Ryman Healthcare - FY26 Annual Report.pdf' - '11_Market_and_Industry_Reports/2026 - Ryman Healthcare - FY26 Annual Report.txt' - '11_Market_and_Industry_Reports/2026 - Ryman Healthcare - Source Brief - FY26 Annual Report.md' The source brief comprehensively captures the financial results, strategy, and commentary. Media release 'FY26 marks significant year of progress' by CEO Naomi James: - Operating revenue up 10% to $849M - Operating EBITDAF up 94% to $88M (nearly doubled) - First positive free cash flow in a decade: $188M - PBTF loss reduced from -$385M to -$73M - Gearing at sector-low 27.8% — balance sheet reset complete - No bank maturities until FY31; >75% of drawn debt on fixed rates - New capital management framework with pathway to return to dividends in FY28 - https://www.rymanhealthcare.co.nz/investor-news/fy26-marks-significant-year-of-progress (opens in a new tab) (accessed 8 Jun 2026) - https://www.nzx.com/announcements/473286 (opens in a new tab) (accessed 8 Jun 2026) Ryman announced it is considering a 6-year fixed rate secured bond offer to replace its $150M RYM010 retail bond maturing December 2026. The offer would be to institutional and retail NZ investors. Full details expected week beginning 8 June 2026. RYM010 bondholders may be able to exchange existing bonds for new ones. - Arranger: ANZ Bank New Zealand - Joint L
Read bundled source notes
The saved source file may include fuller notes and references than the indexed summary. Check its dates and evidence limits.
Loading saved source notes…
Document Details & Metadata
Related Resources
Historical FY2024 operator report on care occupancy, resident and employee feedback, development, audited financial statements, climate scenarios and governance; underlying profit and care-quality narrative have separate assurance limits.
Its Martin Oettli profile records his June 2011 start as Real Living chief executive, growth of the group from one Pakuranga village to four Auckland villages, two with co-located care, and his prior executive, governance and international sector experience.
FY2024 care operator report on high-acuity beds, employee and resident feedback, RConnect staffing, community activity, new home-support plans and audited financial results; 49 PDF spreads contain the numbered report through page 95.
Historical FY2025 report covering village and co-located care capacity, mixed unit/suite completions, workforce feedback, development plans, emissions accounting and audited financial statements; portfolio excludes the Palmerston North joint venture.
42-page FY2026 financial annual report with a short portfolio and leadership overview, audited statements, valuation and resident-loan notes, planned development and limited resident-feedback reporting; separate from the two-page results release.
Two-page issuer results release linking unaudited underlying EBITDA, mixed care-suite/apartment completions and portfolio growth to the year ended March 2026; should be read with the full financial annual report, doc-0194.